https://ab-bispec.accmed.org/linfomi-diffusi-a-grandi-cellule-b-dlbcl
Linfomi diffusi a grandi cellule B (DLBCL)
Portale informativo su anticorpi bispecifici
grandicelluleb
https://www.sobi.com/uk/en/diffuse-large-b-cell-lymphoma
Diffuse large B-cell lymphoma (DLBCL) | Sobi
Diffuse large B-cell lymphoma is a fast-growing blood cancer affecting the lymphatic system. Learn about DLBCL symptoms, treatments, diagnosis and outcomes
diffuselargebcelllymphoma
https://research.jku.at/en/activities/targeting-immune-evading-pro-senescent-dlbcl-mutants/
Targeting immune-evading pro-senescent DLBCL mutants - JKU & KUK Research Portal
targetingimmunepro
https://www.technavio.com/talk-to-us?report=IRTNTR73132&type=sample&src=report&block=infographics1
Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market Size to Grow by USD 2.46 Billion from...
https://studies.sanguinebio.com/condition/dlbcl/
Diffuse Large B-Cell Lymphoma (DLBCL) - Sanguine
diffuselargebcelllymphoma
https://healthtree.org/dlbcl/community/articles/chemotherpy-free-study-for-dlbcl
MD Anderson's Chemotherpy-Free Study for DLBCL - HealthTree for Large B Cell Lymphoma
Dr. Jason Westin shares with HealthTree about an innovative clinical trial that could revolutionize treatment for patients with DLBCL.
https://radioxlogs.com/2025/06/01/can-new-biomarker-help-identify-high-risk-dlbcl-patients/
Can New Biomarker Help Identify High-Risk DLBCL Patients? - RadioXlogs - The Radiology News...
Jun 1, 2025 - Minimal residual disease-negativity after treatment in DLBCL strongly correlates with remission and overall survival. However, clinical trials are needed to...
https://www.hmpgloballearningnetwork.com/site/jcp/conference-coverage/seer-analysis-highlights-risk-factors-advanced-dlbcl-diagnosis
SEER Analysis Highlights Risk Factors for Advanced DLBCL at Diagnosis
A large SEER-based analysis shows that logistic regression can accurately predict advanced-stage diffuse large B-cell lymphoma (DLBCL) at diagnosis,...
risk factorsfor advancedseeranalysishighlights
https://jdc.jefferson.edu/medoncfp/145/
"Treating Early-Stage DLBCL on the FLYER: What Lesson for Radiation The" by Kelsey Sokol, Amanda...
By Kelsey Sokol, Amanda McBride, Adam Binder, et al., Published on 06/04/21
https://www.oncotarget.com/article/9271/text/
A comparison of REPOCH and RCHOP as a firstline regimen in de novo DLBCL patients with high Ki67...
https://doi.org/10.18632/oncotarget.9271 Jia-Jia Huang, Yi Xia, Yu Wang, Pan-Pan Liu, Xi-Wen Bi, Peng Sun, Tong-Yu Lin, Wen-Qi Jiang, Zhi-Ming Li
https://addon.life/resources/dlbcl-lymphoma-nutrition
DLBCL Diet: Nutrition During Lymphoma Treatment | addon
Mar 11, 2026 - What to eat during DLBCL treatment. Evidence-based food guidance for lymphoma patients and caregivers.
lymphoma treatmentdlbcldietnutritionaddon
https://biz.chosun.com/en/en-science/2026/03/08/LL3JWREKZZAN5IWYDKUS67T6ZU/
Bispecifics challenge CAR-T as Korea reshapes DLBCL reimbursement battle - CHOSUNBIZ
Mar 7, 2026 - Bispecifics challenge CAR-T as Korea reshapes DLBCL reimbursement battle Pricing power shifts to fixed-duration Columvi as Epkinlys OS miss clouds tal
challenge carbispecifics
https://ega-archive.org/datasets/EGAD00001008131
RNA-Seq of 584 DLBCL Cases of Non-China Cohort from Phoenix Clinical Trial - EGA European...
Standard RNA-Seq datasets. Check the associated paper for more details.
https://www.rxteach.com/heme-malignancies-dlbcl/
Hematological Malignancies: Diffuse Large B-Cell Lymphoma (DLBCL)
Feb 5, 2025 - This article provides a high-level overview of the evolution of DLBCL treatment, unmet clinical needs, diagnosis, immunophenotyping, and future therapeutic...
hematological malignanciesdiffuselargebcell
https://www.technavio.com/talk-to-us?report=IRTNTR73132&type=sample&src=report&block=infographics3
Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market Size to Grow by USD 2.46 Billion from...
https://lymphomahub.com/medical-information/how-effective-is-the-combination-of-tafasitamab-and-lenalidomide-in-treating-rr-dlbcl
How effective is the combination of tafasitamab and lenalidomide in treating R/R DLBCL?
The Lymphoma Hub was pleased to speak to Gilles Salles, Memorial Sloan Kettering Cancer Center, New York, US. We asked, How effective is the combination of...
https://elifesciences.org/reviewed-preprints/92841/reviews
Tumor Purity-Related Genes for Predicting the Prognosis and Drug Sensitivity of DLBCL Patients